Raymond Dwek
Fortuna: 974 435 $ al 31/05/2026
Fortuna: 974 435 $ al 31/05/2026
Raymond Allen Dwek is an Independent Director at United Therapeutics Corp.
since 2002.
Mr. Dwek is a Professor at the University of Oxford from 2006 to 2009.
Formerly, Mr. Dwek was Chairman-Technology & Society at The Library of Congress (District of Columbia).
Mr. Dwek was Director at Oxford GlycoSciences Plc from 1988 to 2003.
Mr. Dwek was Director-Emeritus at Oxford Glycobiology Institute from 1988 to 2021.
Mr. Dwek was President of the Institute of Biology from 2008 to 2010.
Education includes undergraduate and graduate degrees from the University of Oxford.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/04/2026 | 1.750 ( 0 % ) | 974 435 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1988 |
| Empresas | Cargo | Fin |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Director/Miembro de la Junta | 26/06/2026 |
Oxford Glycobiology Institute
Oxford Glycobiology Institute Other Consumer ServicesConsumer Services Functions as a College/University | Director/Miembro de la Junta | 01/01/2021 |
Institute of Biology | Presidente | 01/01/2010 |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Director/Miembro de la Junta | 01/01/2003 |
The Library of Congress (District of Columbia)
The Library of Congress (District of Columbia) General GovernmentGovernment Engages in library services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
The Library of Congress (District of Columbia)
The Library of Congress (District of Columbia) General GovernmentGovernment Engages in library services | Government |
Institute of Biology | |
Oxford Glycobiology Institute
Oxford Glycobiology Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.